|
Real-time Estimate
Cboe BZX
09:32:40 2026-10-06 EDT
|
5-day change | 1st Jan Change | ||
| 29.88 USD | +0.66% |
|
-2.94% | -50.53% |
| 09-29 | Wells Fargo Adjusts Price Target on Rollins to $27 From $32, Keeps Underweight Rating | MT |
| 09-29 | Morgan Stanley Adjusts Price Target on Rollins to $45 From $60, Keeps Overweight Rating | MT |
| Fiscal Period: December | 2016 (USD) | 2017 (USD) | 2018 (USD) | 2019 (USD) | 2020 (USD) | 2021 (USD) | 2022 (USD) | 2023 (USD) | 2024 (USD) | 2025 (USD) |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 14.37 | 14.88 | 15.67 | 15.17 | 15.29 | |||||
Return on Total Capital | 19.34 | 19.78 | 20.68 | 19.96 | 20.01 | |||||
Return On Equity % | 34.66 | 31 | 35.91 | 37.52 | 38.94 | |||||
Return on Common Equity | 34.66 | 31 | 35.91 | 37.52 | 38.94 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 52.04 | 51.47 | 52.17 | 52.69 | 52.75 | |||||
SG&A Margin | 30.01 | 29.78 | 29.68 | 29.95 | 30.05 | |||||
EBITDA Margin % | 22.03 | 21.69 | 22.49 | 22.74 | 22.71 | |||||
EBITA Margin % | 20.36 | 20.37 | 21.41 | 21.73 | 21.79 | |||||
EBIT Margin % | 18.15 | 18.3 | 19.25 | 19.39 | 19.39 | |||||
Income From Continuing Operations Margin % | 14.47 | 13.67 | 14.15 | 13.76 | 14 | |||||
Net Income Margin % | 14.47 | 13.67 | 14.15 | 13.76 | 14 | |||||
Net Avail. For Common Margin % | 14.47 | 13.67 | 14.15 | 13.76 | 14 | |||||
Normalized Net Income Margin | 11.43 | 11.57 | 11.78 | 11.6 | 11.66 | |||||
Levered Free Cash Flow Margin | 14.58 | 13.63 | 15.97 | 14.7 | 14.76 | |||||
Unlevered Free Cash Flow Margin | 14.6 | 13.69 | 16.36 | 15.21 | 15.24 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 1.27 | 1.3 | 1.3 | 1.25 | 1.26 | |||||
Fixed Assets Turnover | 7.11 | 7.54 | 7.69 | 7.21 | 6.9 | |||||
Receivables Turnover (Average Receivables) | 15.35 | 15.18 | 15.19 | 15.01 | 15.55 | |||||
Inventory Turnover (Average Inventory) | 38.9 | 44.6 | 46.57 | 43.98 | 43.07 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 0.72 | 0.71 | 0.71 | 0.69 | 0.6 | |||||
Quick Ratio | 0.58 | 0.58 | 0.56 | 0.51 | 0.44 | |||||
Operating Cash Flow to Current Liabilities | 0.82 | 0.94 | 0.92 | 0.94 | 0.86 | |||||
Days Sales Outstanding (Average Receivables) | 23.77 | 24.04 | 24.03 | 24.39 | 23.47 | |||||
Days Outstanding Inventory (Average Inventory) | 9.38 | 8.18 | 7.84 | 8.32 | 8.47 | |||||
Average Days Payable Outstanding | 17.16 | 12.18 | 11.39 | 11.24 | 9.63 | |||||
Cash Conversion Cycle (Average Days) | 15.99 | 20.05 | 20.47 | 21.47 | 22.31 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 37.22 | 26.54 | 70.64 | 61.07 | 75.53 | |||||
Total Debt / Total Capital | 27.13 | 20.97 | 41.4 | 37.91 | 43.03 | |||||
LT Debt/Equity | 28.54 | 18.69 | 62.67 | 51.95 | 56.53 | |||||
Long-Term Debt / Total Capital | 20.8 | 14.77 | 36.72 | 32.25 | 32.21 | |||||
Total Liabilities / Total Assets | 45.38 | 40.28 | 55.48 | 52.81 | 56.24 | |||||
EBIT / Interest Expense | 530.11 | 187.03 | 31.04 | 23.75 | 25.54 | |||||
EBITDA / Interest Expense | 756.2 | 258.76 | 42.86 | 33.26 | 35.76 | |||||
(EBITDA - Capex) / Interest Expense | 723.43 | 247.15 | 41.15 | 32.26 | 34.78 | |||||
Total Debt / EBITDA | 0.64 | 0.49 | 1 | 0.88 | 1.02 | |||||
Net Debt / EBITDA | 0.45 | 0.35 | 0.87 | 0.78 | 0.92 | |||||
Total Debt / (EBITDA - Capex) | 0.67 | 0.52 | 1.04 | 0.91 | 1.05 | |||||
Net Debt / (EBITDA - Capex) | 0.47 | 0.37 | 0.91 | 0.81 | 0.94 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 12.17 | 11.2 | 14 | 10.26 | 10.99 | |||||
Gross Profit, 1 Yr. Growth % | 13.4 | 9.97 | 15.57 | 11.36 | 11.12 | |||||
EBITDA, 1 Yr. Growth % | 17.04 | 9.46 | 18.22 | 11.95 | 10.85 | |||||
EBITA, 1 Yr. Growth % | 18.71 | 11.23 | 19.84 | 12.44 | 11.3 | |||||
EBIT, 1 Yr. Growth % | 19.53 | 10.22 | 19.89 | 11.69 | 10.96 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 34.45 | 3.37 | 18 | 7.22 | 12.93 | |||||
Net Income, 1 Yr. Growth % | 34.45 | 3.37 | 18 | 7.22 | 12.93 | |||||
Normalized Net Income, 1 Yr. Growth % | 22.67 | 10.63 | 18 | 10.43 | 11.62 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 33.96 | 3.99 | 18.57 | 8.14 | 13.33 | |||||
Accounts Receivable, 1 Yr. Growth % | 10.45 | 14.27 | 13.66 | 9.82 | 4.59 | |||||
Inventory, 1 Yr. Growth % | -6.22 | 2.83 | 12.23 | 18.42 | 8.73 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | -0.6 | 10.52 | 12.93 | 21.66 | 2.11 | |||||
Total Assets, 1 Yr. Growth % | 7.31 | 4.97 | 22.31 | 8.64 | 11.38 | |||||
Tangible Book Value, 1 Yr. Growth % | -30.45 | -79.38 | 1.63K | -18.71 | 56.61 | |||||
Common Equity, 1 Yr. Growth % | 14.95 | 14.04 | -8.81 | 15.15 | 3.29 | |||||
Cash From Operations, 1 Yr. Growth % | -7.8 | 15.96 | 13.4 | 15.01 | 11.59 | |||||
Capital Expenditures, 1 Yr. Growth % | 17.07 | 12.63 | 6 | -15.07 | 1.86 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -2.57 | 4.85 | 33.61 | 1.91 | 11.65 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -3.28 | 5.17 | 36.24 | 2.94 | 11.37 | |||||
Dividend Per Share, 1 Yr. Growth % | 41.67 | 26.47 | 25.58 | 13.89 | 10.16 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 9.67 | 11.69 | 12.59 | 12.12 | 10.63 | |||||
Gross Profit, 2 Yr. CAGR % | 11.12 | 11.67 | 12.73 | 13.44 | 11.24 | |||||
EBITDA, 2 Yr. CAGR % | 15.78 | 13.31 | 13.76 | 14.79 | 11.4 | |||||
EBITA, 2 Yr. CAGR % | 16.79 | 15.06 | 15.46 | 15.81 | 11.87 | |||||
EBIT, 2 Yr. CAGR % | 17.74 | 14.54 | 14.95 | 15.42 | 11.33 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 31.32 | 17.55 | 10.45 | 12.48 | 10.04 | |||||
Net Income, 2 Yr. CAGR % | 31.32 | 17.55 | 10.45 | 12.48 | 10.04 | |||||
Normalized Net Income, 2 Yr. CAGR % | 30.29 | 17.28 | 13.85 | 13.19 | 11.02 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 31.59 | 17.75 | 11.04 | 13.23 | 10.7 | |||||
Accounts Receivable, 2 Yr. CAGR % | 6.9 | 12.34 | 13.96 | 11.72 | 7.18 | |||||
Inventory, 2 Yr. CAGR % | 21.87 | -1.8 | 7.43 | 15.28 | 13.47 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | -7.39 | 4.81 | 11.72 | 17.21 | 13.95 | |||||
Total Assets, 2 Yr. CAGR % | 6.56 | 7.22 | 13.31 | 15.27 | 10 | |||||
Tangible Book Value, 2 Yr. CAGR % | -6.96 | -60.42 | 89.07 | 275.41 | 9.46 | |||||
Common Equity, 2 Yr. CAGR % | 15.17 | 16.02 | 1.98 | 2.47 | 9.06 | |||||
Cash From Operations, 2 Yr. CAGR % | 12.13 | 3.4 | 14.67 | 14.2 | 13.29 | |||||
Capital Expenditures, 2 Yr. CAGR % | 0.09 | 14.83 | 9.26 | -5.12 | -6.99 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 18.99 | 1.21 | 18.36 | 16.46 | 6.56 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 18.06 | 0.99 | 19.7 | 18.2 | 6.97 | |||||
Dividend Per Share, 2 Yr. CAGR % | 10.19 | 33.85 | 26.03 | 19.59 | 12.01 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 10 | 10.18 | 12.45 | 11.81 | 11.74 | |||||
Gross Profit, 3 Yr. CAGR % | 10.82 | 10.73 | 12.95 | 12.27 | 12.66 | |||||
EBITDA, 3 Yr. CAGR % | 12.38 | 13.63 | 14.92 | 12.98 | 13.46 | |||||
EBITA, 3 Yr. CAGR % | 12.56 | 14.91 | 16.63 | 14.26 | 14.29 | |||||
EBIT, 3 Yr. CAGR % | 12.42 | 15.84 | 16.29 | 13.66 | 13.91 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 14.82 | 21.93 | 17.7 | 9.36 | 12.63 | |||||
Net Income, 3 Yr. CAGR % | 14.82 | 21.93 | 17.7 | 9.36 | 12.63 | |||||
Normalized Net Income, 3 Yr. CAGR % | 12.68 | 24.08 | 16.88 | 12.06 | 12.66 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 14.74 | 22.23 | 18.02 | 10.06 | 13.27 | |||||
Accounts Receivable, 3 Yr. CAGR % | 10.61 | 9.3 | 12.78 | 12.56 | 9.29 | |||||
Inventory, 3 Yr. CAGR % | 22.36 | 15.16 | 2.67 | 10.97 | 13.06 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 35.41 | -1.77 | 7.45 | 14.94 | 13.61 | |||||
Total Assets, 3 Yr. CAGR % | 21.88 | 6.75 | 12.03 | 11.73 | 13.96 | |||||
Tangible Book Value, 3 Yr. CAGR % | 7.53 | -42.01 | 39.52 | 42.7 | 174.89 | |||||
Common Equity, 3 Yr. CAGR % | 14.98 | 15.81 | 7.07 | 6.19 | 2.74 | |||||
Cash From Operations, 3 Yr. CAGR % | 10.3 | 13.39 | 6.63 | 14.78 | 13.32 | |||||
Capital Expenditures, 3 Yr. CAGR % | 0.02 | 4.1 | 11.81 | 0.46 | -2.85 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 14.32 | 13.76 | 11.02 | 12.45 | 14.75 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 14.37 | 13.28 | 11.59 | 13.68 | 15.8 | |||||
Dividend Per Share, 3 Yr. CAGR % | 10.79 | 15.37 | 31.04 | 21.84 | 16.36 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 9.03 | 10 | 11.03 | 10.95 | 11.72 | |||||
Gross Profit, 5 Yr. CAGR % | 9.51 | 10.19 | 11.58 | 11.81 | 12.26 | |||||
EBITDA, 5 Yr. CAGR % | 11.53 | 10.77 | 12.93 | 14.09 | 13.4 | |||||
EBITA, 5 Yr. CAGR % | 11.54 | 11.18 | 13.71 | 15.27 | 14.59 | |||||
EBIT, 5 Yr. CAGR % | 11.12 | 10.91 | 13.82 | 15.67 | 14.16 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 15.94 | 15.53 | 13.43 | 18.06 | 14.58 | |||||
Net Income, 5 Yr. CAGR % | 15.94 | 15.53 | 13.43 | 18.06 | 14.58 | |||||
Normalized Net Income, 5 Yr. CAGR % | 11.28 | 11.14 | 13.32 | 19.21 | 14.11 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 15.87 | 15.44 | 13.56 | 18.55 | 15.04 | |||||
Accounts Receivable, 5 Yr. CAGR % | 9.67 | 10.48 | 11.94 | 10.26 | 10.5 | |||||
Inventory, 5 Yr. CAGR % | 16.08 | 14.7 | 16.16 | 15.21 | 6.86 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 20.55 | 22.88 | 25.38 | 5.42 | 10 | |||||
Total Assets, 5 Yr. CAGR % | 16.67 | 15.47 | 18.86 | 10.08 | 11.21 | |||||
Tangible Book Value, 5 Yr. CAGR % | -3.79 | -21.31 | 37.17 | 22.41 | 26.61 | |||||
Common Equity, 5 Yr. CAGR % | 13.74 | 14.15 | 10.17 | 10.28 | 7.86 | |||||
Cash From Operations, 5 Yr. CAGR % | 12.14 | 14.63 | 12.03 | 13.71 | 9.25 | |||||
Capital Expenditures, 5 Yr. CAGR % | -3.84 | 4.41 | 3.62 | 0.31 | 3.87 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 11.72 | 9.14 | 15.72 | 14.83 | 9.13 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 11.75 | 9.24 | 16.28 | 15.22 | 9.63 | |||||
Dividend Per Share, 5 Yr. CAGR % | 14.43 | 16.54 | 16.65 | 17.04 | 23.07 |
- Stock Market
- Stocks
- ROL Stock
- Financials Rollins, Inc.
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
















